Big Buttons

• End Drug Shortages Act intro’d in Congress

  The legislation would expand the sources the FDA may use to declare drug shortages. read more →

• FDA tirzepatide ‘reconsideration’ period extended

  FDA agreed to extend until December 19 a final report on tirzepatide availability to the court.  read more →

• NPR hits the GLP-1 nail on the head

  A National Public Radio piece this week tackled the issue of compounded GLP-1 drugs and got the facts and nuance just right. read more →

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

More News

The latest in APC’s suite of briefing documents for prescribers is available. It’s titled “Compounding for Racehorses: An Overview for Veterinarians,” and it summarizes regulation governing the use of compounded medications for racehorses.

Horseracing is a tightly regulated sport and has specific rules and regulations regarding the use of drugs in horses. The new anti-doping and medication control program launched by the Horseracing Integrity and Safety Authority in March 2023 addresses the use of banned and non-approved substances in horseracing. However—contrary to persistent rumor—compounded medications are not prohibited under the program.

The HISA rule—and our prescriber brief—emphasizes that veterinarians can continue to rely on compounding pharmacies to provide medications for their racehorses provided compounding pharmacies comply with the Animal Medicinal Drug Use Clarification Act (AMDUCA) and FDA GFI #256 (Compounding Animal Drugs from Bulk Drug Substances).

APC’s prescriber briefs are a members-only resource. You’ll need your APC login and password to access them.